Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “GLIOBLASTOMA MULTIFORME”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04842513
What this trial is testing

Multi Peptide Vaccination with XS15 in Addition to Standard Postoperative Radiation Therapy and Temozolomide Chemotherapy in Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma Multiforme of Brain
University Hospital Tuebingen 15
Testing effectiveness (Phase 2)UnknownNCT04388033
What this trial is testing

Clinical Study of an Dendritic and Glioma Cells Fusion Vaccine With IL-12 for Treatment-naïve GBM Patients.

Who this might be right for
GlioblastomaGliomaNeoplasms, Neuroepithelial+5 more
Second Affiliated Hospital, Zhejiang University, School of Medicine 10
Very early researchLooking for participantsNCT05423210
What this trial is testing

Atezolizumab and Pre-Surgical Brain Radiation Therapy for Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Stony Brook University 12
Early research (Phase 1)Study completedNCT03493932
What this trial is testing

Cytokine Microdialysis for Real-Time Immune Monitoring in Glioblastoma Patients Undergoing Checkpoint Blockade

Who this might be right for
Glioblastoma
National Institute of Neurological Disorders and Stroke (NINDS) 21
Testing effectiveness (Phase 2)UnknownNCT02430363
What this trial is testing

Evaluation Of The Treatment Effectiveness Of Glioblastoma / Gliosarcoma Through The Suppression Of The PI3K/Akt Pathway In Compared With MK-3475

Who this might be right for
Glioblastoma
Medical Research Council 58
Not applicableStudy completedNCT03439332
What this trial is testing

Multicentre Validation of How Vascular Biomarkers From Tumor Can Predict the Survival of the Patient With Glioblastoma

Who this might be right for
Glioblastoma
Juan M Garcia-Gomez 305
Not applicableWithdrawnNCT02919332
What this trial is testing

Delayed 18F-FDG PET/CT in Improving Visualization of Brain Tumors in Patients With Glioblastoma

Who this might be right for
GlioblastomaGlioma
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00883298
What this trial is testing

Bi-weekly Temozolomide Plus Bevacizumab for Adult Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
Recurrent Glioblastoma MultiformeRecurrent Gliosarcoma
Center for Neurosciences, Tucson 30
Not applicableStudy completedNCT03865355
What this trial is testing

Blood and Cerebrospinal Fluid Metabolomic Profile in Glioma Patients

Who this might be right for
GliomaGlioblastoma Multiforme
Novosibirsk State University 50
Very early researchUnknownNCT04045847
What this trial is testing

CD147-CART Cells in Patients With Recurrent Malignant Glioma.

Who this might be right for
Recurrent GlioblastomaCD147 Positive
Xijing Hospital 31
Early research (Phase 1)Study completedNCT00132158
What this trial is testing

ZD1839 and Oral Irinotecan in Treating Young Patients With Refractory Solid Tumors

Who this might be right for
GlioblastomaRhabdomyosarcomasNeuroblastoma+1 more
St. Jude Children's Research Hospital 19
Early research (Phase 1)Looking for participantsNCT07244835
What this trial is testing

DEG6498 in Participants With Solid Tumors

Who this might be right for
Malignant Neoplasms
Degron Therapeutics Co. 100
Not applicableWithdrawnNCT02590497
What this trial is testing

Correlation Between the Genetic and Neuroimaging Signatures in Newly Diagnosed Glioblastoma Patients Before Surgery

Who this might be right for
Glioblastoma
Ohio State University Comprehensive Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT03897491
What this trial is testing

PD L 506 for Stereotactic Interstitial Photodynamic Therapy of Newly Diagnosed Supratentorial IDH Wild-type Glioblastoma

Who this might be right for
Glioblastoma
photonamic GmbH & Co. KG 17
Testing effectiveness (Phase 2)Active Not RecruitingNCT04752813
What this trial is testing

BPM31510 With Vitamin K1 in Subjects With Newly Diagnosed Glioblastoma (GB)

Who this might be right for
GlioblastomaGlioblastoma Multiforme
BPGbio 50
Early research (Phase 1)Study completedNCT00022360
What this trial is testing

Taurolidine in Treating Patients With Recurrent or Progressive Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Looking for participantsNCT04541082
What this trial is testing

Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms

Who this might be right for
Central Nervous System NeoplasmsGlioblastomaGliosarcoma, Adult+20 more
Jazz Pharmaceuticals 102
Not applicableLooking for participantsNCT05957679
What this trial is testing

MRE Evaluation for Spinal Cord Tumor Surgery: Stiffness and Adhesion Assessment

Who this might be right for
Spinal Cord Tumors
Shengjing Hospital 20
Not applicableWithdrawnNCT07553520
What this trial is testing

Dietary Cysteine and Methionine Deprivation (CMD) in Glioma Patients

Who this might be right for
Glioblastoma MultiformeRecurrent Glioma
UNC Lineberger Comprehensive Cancer Center
Not applicableStudy completedNCT03900689
What this trial is testing

Social Determinants of Health in Glioblastoma Population

Who this might be right for
GliomaAstrocytomaOligodendroglioma+3 more
Wake Forest University Health Sciences 100
Next Page